Factor V Leiden Is Associated with Higher Risk of Deep Venous Thrombosis of Large Blood Vessels

Arsov, Todor; Miladinova, Daniela; Spiroski, Mirko
June 2006
Croatian Medical Journal;2006, Vol. 47 Issue 3, p433
Academic Journal
Aim To determine the prevalence of factor V Leiden mutation in patients with different presentation of venous thromboembolic disease and healthy individuals in the Republic of Macedonia. Methods The retrospective case control study involved 190 patients with venous thromboembolic disease and 200 healthy individuals, who were screened for the presence of factor V Leiden mutation, using a polymerase chain reaction-restriction fragment length polymorphism method. The prevalence of factor V Leiden was analyzed according to the localization of thrombosis, presence of risk factors, and family history of thrombosis. The odds of deep venous thrombosis were calculated with respect to the presence of factor V Leiden mutation. Results The prevalence of factor V Leiden mutation among patients with venous thromboembolic disease was 21.1%, compared with 5.5% in the healthy individuals. Factor V Leiden positive patients had the first episode of deep venous thrombosis at a younger age, and the prevalence of the mutation was the highest among patients with a positive family history of thrombosis (33.9%, P = 0.003) and in patients with deep venous thrombosis affecting a large blood vessel (37.7%, P = 0.001). The prevalence of factor V Leiden mutation was lower in patients with calf deep venous thrombosis and primary thromboembolism (13.3% and 13.1%, respectively; P>0.05). The odds ratio for iliofemoral or femoral deep venous thrombosis in factor V Leiden carriers was 10.4 (95% confidence interval, 4.7-23.1). Conclusion The prevalence of factor V Leiden mutation was high in patients with venous thromboembolic disease and healthy individuals in the Republic of Macedonia. Factor V Leiden carriers have the highest odds of developing deep venous thrombosis affecting a large venous blood vessel.


Related Articles

  • Review: Several factors are associated with the performance of D-dimer assays for detecting deep venous thrombosis.  // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p76 

    The article addresses the question as to which factors are associated with the performance of D-dimer assays for detecting lower-extremity deep venous thrombosis (DVT) in symptomatic patients. The article adds that in symptomatic patients, biochemical and technical characteristics of the assays,...

  • Exercise-Induced Changes in Coagulation and Fibrinolysis in Healthy Populations and Patients with Cardiovascular Disease. Womack, Christopher; Nagelkirk, Paul R.; Coughlin, Adam M. // Sports Medicine;2003, Vol. 33 Issue 11, p795 

    Highlights the clinical significance of coagulation and fibrinolytic responses, and adaptations in healthy individuals and patients with cardiovascular disease. Responses of coagulation to exercise; Exercise responses in fibrinolysis; Indicators of the potential for coagulation and fibrinolysis.

  • Deep vein thrombosis after total hip and knee arthroplasty in Indian patients. Jain, V.; Dhaon, B. K.; Jaiswal, A.; Nigam, V.; Singla, J. // Postgraduate Medical Journal;Dec2004, Vol. 80 Issue 950, p729 

    Background: Deep vein thrombosis (DVT) is one of the most common complications of total hip (THA) and total knee arthroplasty (TKA). Though the reported incidence of DVT is very high, that of proximal DVT is low and that of fatal thromboembolism is very low. Hence the issue of prophylaxis for...

  • Managements for lateral sinus thrombosis: does it need the ligation of internal jugular vein or anticoagulants? Jun Ho Lee; Seong Jun Choi; Keehyun Park; Yun-Hoon Choung // European Archives of Oto-Rhino-Laryngology;Jan2009, Vol. 266 Issue 1, p51 

    The purposes of this study were to review the clinical characteristics and treatment outcomes of patients with lateral sinus thrombosis (LST) and to discuss the need of internal jugular vein (IJV) ligation or anticoagulants. We retrospectively reviewed the charts of five patients (1 male and 4...

  • Clinical significance of determining plasma homocysteine: case-control study on arterial and venous thrombotic patients. Vučković, Biljana A.; Čabarkapa, Velibor S.; Ilić, Tatjana A.; Salatić, Iva R.; Lozanov-Crvenković, Zagorka S.; Mitić, Gorana P. // Croatian Medical Journal;2013, Vol. 54 Issue 5, p480 

    Aim To determine the differences in plasma homocysteine levels between three MTHFR 677 genotype subgroups in patients with thrombosis and in controls, as well as between patients with thrombosis and controls with the same MTHFR 677 genotype. Methods This case-control study was conducted in...

  • Venous Plethysmography Applied in Pathologic Conditions. Boccalon, H.; Chikhany, G.; Lozes, A.; Vaislic, C.; Puel, P.; Enjalbert, A. // Angiology;Dec1981, Vol. 32 Issue 12, p822 

    The correlation between venography and SGP in 41 patients was studied. Fourteen normal subjects were used as a reference. SGP was shown to be very sensitive (97.5%), including proximal and distal DVT, and highly specific (96.4%). After some recommendations for patient positioning and technical...

  • ACOG Practice Bulletin on Preventing Deep Venous Thrombosis and Pulmonary Embolism. Ressel, Genevieve W. // American Family Physician;6/1/2001, Vol. 63 Issue 11, p2279 

    Focuses on a practice bulletin on the prevention of deep venous thrombosis developed by the Committee on Practice Bulletins--Gynecology of the American College of Obstetricians and Gynecologist. Review of the areas of prevention of thromboembolism in gynecologic patients; Recommendations for...

  • Incidence of thrombophilia detected in southern Taiwanese patients with venous thrombosis. Chen, T.-Y.; Su, W.-C.; Tsao, C.-J. // Annals of Hematology;Feb2003, Vol. 82 Issue 2, p114 

    In order to analyze the incidence of thrombophilia in southern Taiwan, we studied the prevalence of antithrombin (AT), protein C (PC), and protein S (PS) deficiencies, the prevalence of factor V Leiden mutation, and the presence of acquired lupus anticoagulant (LA) and anticardiolipin antibody...

  • Purpura fulminans in a child with combined heterozygous prothrombin G20210A and factor V Leiden mutations. Özbek, N.; Ataç, F. B.; Verdi, H.; Kayiran, S. M.; Özbek, N; Ataç, F B; Kayıran, S M // Annals of Hematology;Feb2003, Vol. 82 Issue 2, p118 

    Although thrombosis is relatively rare in children, reports of young patients with thrombosis are becoming more frequent with time. Activated protein C resistance and prothrombin 20210 A mutation are results of point mutations described in the last decade. This article highlights a case of a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics